Last reviewed · How we verify
NCT03546790
Laboratory Smoking of Marijuana "Blunts"
Phase 1 trial testing Marijuana in Cannabis in 8 participants. Completed in 30 September 2019.
30 September 2019
Quick facts
| Lead sponsor | Battelle Memorial Institute |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 8 |
| Start date | 10 April 2019 |
| Primary completion | 30 September 2019 |
| Estimated completion | 30 September 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Marijuana — full drug profile →
Conditions studied
- Cannabis — all drugs for Cannabis →
Sponsor
Battelle Memorial Institute
Who can join
Adults 18 to 55, any sex, with Cannabis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a double-blind within-subjects clinical laboratory study comparing the product appeal and abuse liability-related subjective effects of different flavored cigar wrappers for marijuana blunts.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03546790
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Marijuana
Trials testing the same drug.
- NCT05485012 — Reinforcing Effects of Marijuana and Opioids · Phase 1 · completed
- NCT05114460 — Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal · Phase 2 · terminated
- NCT03699540 — Marijuana Effects on Simulated Driving Performance · Phase 1 · completed
- NCT03253926 — Effect of Lorcaserin on Cannabis Withdrawal and Self-administration · Phase 1, PHASE2 · completed
Other recruiting trials for Cannabis
Currently open trials in the same condition.
- NCT05999383 — Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration · Phase 2 · recruiting
- NCT07417059 — Sex Hormones Impact on Cannabis Response · NA · recruiting
- NCT07194018 — Use of Cannabis Oil in Fibromyalgia · active not recruiting
- NCT06099379 — Modulation of THC Effects by CBD: a Dose-ranging Study · Phase 1, PHASE2 · recruiting
- NCT05742724 — The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol · Phase 1 · active not recruiting
Other Battelle Memorial Institute trials
Trials by the same sponsor.
- NCT05128994 — Hand Grasp Function After Spinal Cord Injury · NA · completed
- NCT06207240 — Functional Electrical Stimulation Therapy After Stroke · NA · completed
- NCT04314713 — A Study to Evaluate the Intramuscular Administration of Scopolamine · Phase 1 · terminated
- NCT03994926 — Evaluation of an Eye Tracking Sensor to Detect Cannabis Impairment · EARLY_PHASE1 · terminated
- NCT02961309 — A Laboratory Model of Increasing Delta-9-tetrahydrocannabinol (THC) Potency on Cigarette Smoking · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03546790 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Battelle Memorial Institute
- Last refreshed: 2 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03546790.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing